Jacqueline Snider

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Maggie C.U. Cheang, Stephen Chia, David Voduc et al. · JNCI Journal of the National Cancer Institute · 2009 · 2.2K citations · Full text

Medicine, Cancer Biology, Oncology +17

Genome remodelling in a basal-like breast cancer metastasis and xenograft

Li Ding, Matthew J. Ellis, Shunqiang Li et al. · Nature · 2010 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +14

Whole-genome analysis informs breast cancer response to aromatase inhibition

Matthew J. Ellis, Li Ding, Dong Shen et al. · Nature · 2012 · 1K citations · Full text

Medicine, Genetics, Oncology +17

A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

Torsten O. Nielsen, Joel S. Parker, Samuel Leung et al. · Clinical Cancer Research · 2010 · 824 citations · Full text

Medicine, Biostatistics, Oncology +16

Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

Matthew J. Ellis, Vera J. Suman, Jeremy Hoog et al. · Journal of Clinical Oncology · 2011 · 560 citations

Medicine, Oncology, Pharmacology +17